SSP
SCLN

Sapphire Star Partners’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Sapphire Star Partners’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,724
Closed -$209K – 116
2017
Q3 		$209K Sell
18,724
-6,110
-25% -$67.4K 0.27% 75
2017
Q2 		$273K Sell
24,834
-5,605
-18% -$56.1K 0.35% 50
2017
Q1 		$298K Buy
30,439
+2,501
+9% +$25K 0.34% 59
2016
Q4 		$302K Buy
+27,938
New +$279K 0.34% 54

Sapphire Star Partners's SCLN Position: Q4 2017 in Review

Sapphire Star Partners sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 18,724 shares — an estimated $209K sold.

Sapphire Star Partners first reported a position in SCLN in Q4 2016 and held it in 4 quarters. The position peaked at $302K in Q4 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Sapphire Star Partners reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Sapphire Star Partners sold 18,724 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $209K.
  • Sapphire Star Partners first reported a position in Sciclone Pharmaceuticals Inc in Q4 2016 and held it in 4 quarters.
  • Sapphire Star Partners's Sciclone Pharmaceuticals Inc position peaked at $302K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Sapphire Star Partners's 13F filing for Q4 2017, filed 14 Feb 2018.